Serum Institute’s Covovax receives Emergency Use Listing (EUL) by WHO, Health News, ET HealthWorld
Geneva: Covovax, produced by Serum Institute of India (SII) under the license from Novovax, became the ninth COVID-19 vaccine to receive Emergency Use Listing (EUL) from the World Health Organisation…

